Ketamine Therapy for Depression in Charlotte, NC

If you are living with depression that has not lifted despite trying one or more antidepressants, you are not out of options. Ketamine therapy works through a different biological pathway than standard medications, and a growing body of research suggests it can help many people who have not found relief elsewhere. At our clinic in Charlotte, NC, every patient starts with a consultation so a physician can determine whether this approach is a reasonable fit.

When Standard Antidepressants Have Not Worked

Most first line antidepressants, including SSRIs and SNRIs, act on serotonin and related neurotransmitter systems. They help a great many people. For a sizable group, though, the relief is partial or does not arrive at all. When two or more adequately dosed antidepressants have not produced a satisfactory response, that pattern is often described as treatment resistant depression, which we cover in more depth on our page about ketamine for treatment resistant depression.

Living in that gap is exhausting. It is common to feel that you have already tried everything. Ketamine therapy matters here precisely because it does not rely on the same mechanism that has already fallen short for you.

A Different Mechanism Than Traditional Antidepressants

Ketamine acts primarily on the glutamate system, the brain’s most abundant excitatory signaling network. By modulating NMDA receptors (a type of receptor that helps regulate how brain cells communicate), ketamine is thought to promote synaptic plasticity, which is the brain’s capacity to form new connections. Researchers believe this is part of why some people experience rapid shifts in mood. You can read a fuller, plain English explanation on our overview of how ketamine therapy works.

What the Evidence Shows

The research base for ketamine in depression has grown steadily since the early 2000s.

• An early controlled study found that a single intravenous dose of ketamine produced rapid improvement in depressive symptoms, a finding that reshaped how researchers thought about fast acting treatments (Berman et al., 2000).
• A landmark trial at the National Institute of Mental Health reported that many participants with treatment resistant depression experienced significant improvement within a day of a single infusion (Zarate et al., 2006).
• A larger two site randomized controlled trial later reported that a meaningful share of participants with treatment resistant depression responded to ketamine compared with an active control (Murrough et al., 2013).
• A meta analysis of individual patient data found that a single ketamine infusion was associated with a rapid reduction in suicidal thoughts in the days following treatment (Wilkinson et al., 2018).

These results are encouraging, but research also shows that benefits can fade without a maintenance plan, and that ketamine does not help everyone. We share this context openly because honest expectations are part of good care.

Ketamine and Esketamine (Spravato): The Distinction

You may have seen the name Spravato. Spravato is esketamine, a nasal spray derived from one component of the ketamine molecule, and it is separately FDA approved for treatment resistant depression and for depressive symptoms in adults with major depressive disorder who have suicidal thoughts or behavior (FDA, Spravato). Intravenous ketamine, by contrast, is used off label. Both are options worth understanding, and we walk through the practical differences in cost, delivery, and insurance during your consultation.

What Treatment Looks Like for Depression

Most protocols for depression begin with a short series of infusions over two to three weeks, followed by a personalized plan for spacing future sessions. The exact number of sessions depends on your history and how you respond. During each infusion a clinician monitors your vital signs, and you rest in a calm treatment room. Our page on what to expect describes the visit step by step, from arrival to the ride home.

Realistic Outcomes

In published studies, a substantial proportion of participants with hard to treat depression experienced a clinically significant reduction in symptoms after ketamine, often more quickly than with oral antidepressants. That said, response rates vary across studies, some people respond partially, and some do not respond at all. We do not promise outcomes, and we will tell you candidly if we do not think ketamine is the right path for you.

Safety and Screening

Ketamine is not appropriate for everyone. Before treatment, our physician reviews your medical and psychiatric history and screens for conditions that can make ketamine less safe, such as uncontrolled high blood pressure or certain heart conditions. Vital signs are monitored during every infusion, and you are observed during a recovery period afterward. Safety screening is one reason every patient begins with a consultation rather than a booking.

Take the First Step

If standard treatments have not worked, a conversation costs you nothing but a little time. A physician will listen, answer your questions, and help you decide whether ketamine therapy fits your situation. You can also read answers to common questions on our FAQ page before you reach out.

Common Questions About Depression

How quickly might ketamine help my depression?

Many patients notice changes in mood within hours to a few days of an infusion, which is faster than the weeks typical of oral antidepressants. Responses vary, and a series of sessions is usually needed for more durable benefit. We review realistic timelines during your consultation.

Will I have to stop my current antidepressant?

Not necessarily. Many patients continue their existing medications during ketamine therapy. Any medication decisions are made with your prescriber and our physician based on your history. Bring a current medication list to your consultation.

Is ketamine a permanent fix for depression?

No. Ketamine does not permanently eliminate depression, and we never describe it that way. In published studies it has helped many people experience a meaningful reduction in symptoms, often when other treatments did not. Results vary from person to person.

Is ketamine for depression FDA approved?

Ketamine itself is FDA approved as an anesthetic, and its use for depression is off label. A related medication, esketamine (Spravato), is separately FDA approved for treatment resistant depression. We explain the difference during your consultation.